Evidence-based therapy for type 2 diabetes. The best and worst of times

Postgrad Med. 2000 May 1;107(5):27-8, 31-4, 37-40, passim. doi: 10.3810/pgm.2000.5.1.1064.

Abstract

Type 2 diabetes, which is increasing in prevalence, is a multifaceted disease that presents a challenge to the primary care physician. In this article, Drs Flemmer and Vinik review the significant findings of several important clinical trials and present a method of comprehensive staged management to improve the quality of patient care.

Publication types

  • Review

MeSH terms

  • Aged
  • Albuminuria / economics
  • Albuminuria / prevention & control
  • Algorithms
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / epidemiology
  • Drug Therapy, Combination
  • Humans
  • Hyperglycemia / etiology
  • Hyperglycemia / prevention & control
  • Hyperlipidemias / complications
  • Hyperlipidemias / prevention & control
  • Hypertension / complications
  • Hypertension / drug therapy
  • Hypolipidemic Agents / therapeutic use*
  • United Kingdom / epidemiology

Substances

  • Hypolipidemic Agents